Peptide dosage chart.

Turning a dose into syringe units.

A dose in micrograms is not a mark on a syringe. The conversion depends on vial size and how much bacteriostatic water went in, which is arithmetic rather than clinical judgment. Klarovel keeps that arithmetic in dedicated tools instead of repeating it here.

What this table does not publish.

Three peptides in the Klarovel catalog appear in protocols but carry no dose figure here. Publishing an inferred number would be worse than publishing nothing, so the gaps are named instead.

• CJC-1295 (without DAC)No dose figure in the research catalog. The row is flagged as a known gap in the engine coverage test, so no starting dose or ceiling is published.
• SermorelinNo dose figure in the research catalog. Flagged as a known gap in the engine coverage test.
• SelankNo dose figure in the research catalog. Flagged as a known gap in the engine coverage test.

Where a personal dose comes from.

A reference range is not a protocol. Klarovel's rules engine narrows the range using a health questionnaire: contraindications first, then experience tier, then body weight for the compounds where dosing scales with mass, then age caps. Blood work sharpens the result when a person has it, and changes nothing about whether they can get a protocol at all.

The engine also refuses. Pregnancy blocks growth hormone peptides outright. A cancer history blocks the pro-angiogenic compounds. Research suggests several of these interactions are dose independent, so the engine treats them as exclusions rather than reductions.

Klarovel builds the protocol. It does not sell, supply, or ship peptides. Fulfilment sits with partner suppliers, and that separation is set out in the disclosures.

Frequently asked questions about peptide dosage.

What is a standard peptide dose?

There is no single standard. Each peptide has its own range, and the table on this page lists a starting dose and an upper bound per compound. The starting dose is the conservative entry point; the upper bound is the ceiling the Klarovel engine will not exceed when it builds a protocol. Where a person lands between the two depends on their health data, their goals, and their experience with injectable peptides.

How is a peptide dose actually decided?

Klarovel's rules engine starts from the health questionnaire, then applies contraindication checks, experience tier, body weight where the peptide is weight sensitive, and age caps. Blood work is optional. It refines the result when it is available, but a protocol is built from health data and never blocked on a lab panel.

Do peptides need to be cycled?

Most in this reference do. The cycle column shows weeks on and weeks off for each compound. GLP-1 receptor agonists are the exception: semaglutide, tirzepatide, and retatrutide are continuous-use, because stopping is associated with weight regain in the published trial data.

Why do some peptides have no dose listed here?

Because the research catalog carries no figure for them. Rather than infer a number, those compounds are named in the withheld list further down the page with the reason stated. A missing row means missing data, not a judgment about the peptide.

How do I convert a dose into syringe units?

Use the Klarovel peptide reconstitution calculator. It takes vial size, bacteriostatic water volume, and target dose, and returns the exact units to draw. That conversion is arithmetic, not clinical judgment, so a calculator is the right tool for it.

Are these doses a prescription?

No. This page is a reference for what the research catalog supports. It is educational, not medical advice, and it is not a recommendation to use any compound. Peptide use should be discussed with a qualified clinician.